VolitionRx Limited (VNRX)
Develops blood tests that detect cancer and sepsis from tiny DNA fragments in blood
$0.85-0.03%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-93.3%
The outlook
VNRX is trading near its 52-week low with a bearish overall sentiment score. The stock sits well below both its 50- and 200-day moving averages, signaling a weak near-term trend. Analyst targets average roughly 19 times the current price, though coverage appears limited given the extreme disparity.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Price targetAvg target +1893% vs current price
Analyst price target
~12-month · 5 analysts$16.97average target+1893.0% vs now
Now $0.85
Low $4.00High $24.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$10.3M
52-wk high
$15.20
52-wk low
$0.85
50-day avg
$1.66
200-day avg
$4.43
Trailing P/E
—